TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 27 filers reported holding TRACON PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $78,356 | +144.1% | 182,307 | +973.5% | 0.00% | – |
| Q1 2023 | $32,096 | +60.5% | 16,982 | +69.0% | 0.00% | – |
| Q2 2022 | $20,000 | -25.9% | 10,050 | -3.4% | 0.00% | – |
| Q1 2022 | $27,000 | -79.1% | 10,403 | -5.8% | 0.00% | – |
| Q4 2020 | $129,000 | -35.5% | 11,041 | -71.5% | 0.00% | – |
| Q3 2020 | $200,000 | – | 38,749 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,013,438 | $10,409,000 | 2.04% |
| Ikarian Capital, LLC | 2,162,549 | $11,180,000 | 0.81% |
| Telemetry Investments, L.L.C. | 54,723 | $283,000 | 0.62% |
| Vigilare Wealth Management | 17,000 | $88,000 | 0.09% |
| Johnson & Johnson Innovation - JJDC, Inc. | 84,003 | $434,000 | 0.09% |
| NEA Management Company, LLC | 346,718 | $1,793,000 | 0.08% |
| BOOTHBAY FUND MANAGEMENT, LLC | 236,301 | $1,222,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 81,675 | $422,000 | 0.07% |
| Virtu Financial LLC | 61,180 | $316,000 | 0.05% |
| 683 Capital Management, LLC | 75,000 | $388,000 | 0.03% |